By continuing to use the site you agree to our Privacy & Cookies policy

Study questions use of insulin as primary diabetes add-on therapy

Type 2 diabetes patients taking metformin and insulin are at increased risk of death compared to those who take metformin and a sulfonylurea, according to latest research.

Get unlimited access

As a subscriber you will benefit from:

  • Full online and mobile access to news and opinion stories
  • Customised email alerts straight to your inbox (over 30 alerts available)
  • 4,500 practice articles in our archive 
  • Over £500 worth of CPD learning units